CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Vavricka John Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +132,800 | 132,800 | ||
| 2025-01-31 | Horga Maria Arantxa Chief Medical Officer | Option exercise | +41,533 | 67,197 | ||
| 2025-01-31 | Horga Maria Arantxa Chief Medical Officer | Grant or award | +9,750 | 76,947 | ||
| 2025-01-31 | Horga Maria Arantxa Chief Medical Officer | Shares withheld for taxes | −16,071 | $3.06 | $49K | 60,876 |
| 2025-01-31 | Horga Maria Arantxa Chief Medical Officer | Option exercise · Restricted Stock Units | −41,533 | 41,533 | ||
| 2025-01-31 | Horga Maria Arantxa Chief Medical Officer | Grant or award · Restricted Stock Units | +9,750 | 9,750 | ||
| 2025-01-31 | Horga Maria Arantxa Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +192,800 | 192,800 | ||
| 2025-01-31 | Corcoran Andrea See Remarks | Option exercise | +44,367 | 722,909 | ||
| 2025-01-31 | Corcoran Andrea See Remarks | Grant or award | +10,500 | 733,409 | ||
| 2025-01-31 | Corcoran Andrea See Remarks | Shares withheld for taxes | −16,102 | $3.06 | $49K | 717,307 |
| 2025-01-31 | Corcoran Andrea See Remarks | Option exercise · Restricted Stock Units | −44,367 | 44,366 | ||
| 2025-01-31 | Corcoran Andrea See Remarks | Grant or award · Restricted Stock Units | +10,500 | 10,500 | ||
| 2025-01-31 | Corcoran Andrea See Remarks | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2025-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Option exercise | +173,467 | 290,024 | ||
| 2025-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Grant or award | +99,517 | 389,541 | ||
| 2025-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Shares withheld for taxes | −88,601 | $3.06 | $271K | 300,940 |
| 2025-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Option exercise · Restricted Stock Units | −173,467 | 173,466 | ||
| 2025-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Grant or award · Restricted Stock Units | +99,518 | 99,518 | ||
| 2025-01-31 | Sommadossi Jean-Pierre President, CEO, and Chairman | Grant or award · Stock Option (Right to Buy) | +440,000 | 440,000 | ||
| 2025-01-31 | Foster Wayne EVP, Chief Accounting Officer | Option exercise | +33,333 | 54,190 |
Page 6 of 14 · 280 trades